Baxter Nicholas W
- SEC CIK
- 0001312326
No open-market purchases or sales filed in the past year.
Current role at each company
- LEXX Lexaria Bioscience Corp.Directoras of May 16, 2025
- Rhino Biotech LtdPresident and CEOas of Aug 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Baxter Nicholas W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Rhino Biotech Ltd
President and CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 (view filing)7:36 PM ET | Aug 26 | 4 days | Baxter Nicholas WPresident and CEO | SSale | −7.57M | $0.0191 | −$144.7K | −100.0%0 after |